Post-operative chemotherapy improves disease-free survival, but not overall survival in people with oesophageal squamous cell carcinoma.
Leonard
Gregory D
GD
Department of Medicine, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Box 324, New York, NY, USA.
Reilly
Eileen M O
EM
D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery*; D017024:Chemotherapy, Adjuvant; D002945:Cisplatin / Q000008:administration & dosage; D003131:Combined Modality Therapy; D018572:Disease-Free Survival; D004938:Esophageal Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery*; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage; D006801:Humans; D007262:Infusions, Intravenous; D008297:Male; D008875:Middle Aged; D016896:Treatment Outcome
D002945:Cisplatin; D005472:Fluorouracil